ArticleBiochimica et biophysica acta. Molecular basis of disease2024

Therapeutic targeting of HYPDH/PRODH2 with N-propargylglycine offers a Hyperoxaluria treatment opportunity.

Joanna Bons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.